Emcure Pharmaceuticals shareholding pattern

EMCURE

HealthcareLarge

1453.5

1.30 (-0.09%)
Last updated on 18 Aug, 2025 | 15:51 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Emcure Pharmaceuticals Shareholding Pattern

  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

77.91%

Mutual Fund

2.34%

Insurance

0.24%

Foreign Institutional Investors

2.86%

Domestic Institutional Investors

0.26%

Retail

16.39%

Others

0%

Total Promoters
MAR '25
77.92%
JUN '25
77.91%

Emcure Pharmaceuticals FAQs

As of 08-2025, the promoter shareholding in Emcure Pharmaceuticals stands at 77.91% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Emcure Pharmaceuticals is 2.86% and 0.26% respectively.

The retail shareholding of the Emcure Pharmaceuticals is 16.39%.

Changes in shareholding patterns of Emcure Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Emcure Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.